|
|
Volumn 10, Issue 6, 2009, Pages 530-531
|
|
Late treatment effects: reframing the questions
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DOXORUBICIN;
ACUTE TOXICITY;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CANCER SURVIVOR;
CANCER THERAPY;
CARDIOTOXICITY;
CARDIOVASCULAR SYSTEM;
EVIDENCE BASED PRACTICE;
FATIGUE;
FIBROSIS;
FUNCTIONAL DISEASE;
HEAD AND NECK CANCER;
HUMAN;
LETTER;
NUTRITIONAL STATUS;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SCORING SYSTEM;
SOCIAL STATUS;
SYMPTOM;
THERAPY EFFECT;
XEROSTOMIA;
ANTINEOPLASTIC AGENTS;
HUMANS;
NEOPLASMS;
SURVIVORS;
TREATMENT OUTCOME;
|
|
EID: 66149146313
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(09)70118-4 Document Type: Letter |
|
Times cited : (16)
|
|
References (0)
|
